Cargando…

Nanogel loaded with surfactant based nanovesicles for enhanced ocular delivery of acetazolamide

Objective: Intraocular pressure has always been a great challenge for topical ophthalmic drugs. The study aimed to develop ocular surfactant based nanovesicles (NVs) carried in mucoadhesive nanogel providing efficient topical delivery of acetazolamide (ACZ). Methods: For the sake of optimizing formu...

Descripción completa

Detalles Bibliográficos
Autores principales: Abdel-Rashid, Rania S, Helal, Doaa A, Omar, Mahmoud M, El Sisi, Amani M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6503338/
https://www.ncbi.nlm.nih.gov/pubmed/31118616
http://dx.doi.org/10.2147/IJN.S201891
_version_ 1783416389369856000
author Abdel-Rashid, Rania S
Helal, Doaa A
Omar, Mahmoud M
El Sisi, Amani M
author_facet Abdel-Rashid, Rania S
Helal, Doaa A
Omar, Mahmoud M
El Sisi, Amani M
author_sort Abdel-Rashid, Rania S
collection PubMed
description Objective: Intraocular pressure has always been a great challenge for topical ophthalmic drugs. The study aimed to develop ocular surfactant based nanovesicles (NVs) carried in mucoadhesive nanogel providing efficient topical delivery of acetazolamide (ACZ). Methods: For the sake of optimizing formulation parameters, the effect of the type of edge activator and its ratio to sorbitan monostearate (Span 60) on the mean particle size, entrapment efficiency (%EE), and zeta potential (ZP) of produced NVs was investigated. Results: The selected formulation composed of Span 60:sodium deoxycholate with ratio 80:20 showed an average diameter of 202.90 nm, %EE of 90.2%, and ZP of −38.1 mV with a spherical and smooth surface. The ACZ loaded nanovesicles (ACZ-NVs) were embedded in different concentrations of Chitosan–sodium tripolyphosphate (CS-TPP) nanogels. The nanogel prepared using 1.5% CS showed the most promising viscosity, adhesion time, and rheological behavior (118,246 cP, 290 min, and thixotropic behavior, respectively). The in vitro release of ACZ showed a controlled release profile after incorporation in nanogels. The in vivo irritation test showed minimal irritation for the nanogel formulation compared to ACZ topical suspension. The effect of intraocular pressure lowering was significantly prolonged using ACZ-NV nanogels compared to ACZ oral tablets. Histopathological examination emphasized the healing power of CS on retinal atrophy. Conclusion: The research work indicated a promising potential for successful topical delivery of ACZ.
format Online
Article
Text
id pubmed-6503338
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-65033382019-05-22 Nanogel loaded with surfactant based nanovesicles for enhanced ocular delivery of acetazolamide Abdel-Rashid, Rania S Helal, Doaa A Omar, Mahmoud M El Sisi, Amani M Int J Nanomedicine Original Research Objective: Intraocular pressure has always been a great challenge for topical ophthalmic drugs. The study aimed to develop ocular surfactant based nanovesicles (NVs) carried in mucoadhesive nanogel providing efficient topical delivery of acetazolamide (ACZ). Methods: For the sake of optimizing formulation parameters, the effect of the type of edge activator and its ratio to sorbitan monostearate (Span 60) on the mean particle size, entrapment efficiency (%EE), and zeta potential (ZP) of produced NVs was investigated. Results: The selected formulation composed of Span 60:sodium deoxycholate with ratio 80:20 showed an average diameter of 202.90 nm, %EE of 90.2%, and ZP of −38.1 mV with a spherical and smooth surface. The ACZ loaded nanovesicles (ACZ-NVs) were embedded in different concentrations of Chitosan–sodium tripolyphosphate (CS-TPP) nanogels. The nanogel prepared using 1.5% CS showed the most promising viscosity, adhesion time, and rheological behavior (118,246 cP, 290 min, and thixotropic behavior, respectively). The in vitro release of ACZ showed a controlled release profile after incorporation in nanogels. The in vivo irritation test showed minimal irritation for the nanogel formulation compared to ACZ topical suspension. The effect of intraocular pressure lowering was significantly prolonged using ACZ-NV nanogels compared to ACZ oral tablets. Histopathological examination emphasized the healing power of CS on retinal atrophy. Conclusion: The research work indicated a promising potential for successful topical delivery of ACZ. Dove 2019-04-29 /pmc/articles/PMC6503338/ /pubmed/31118616 http://dx.doi.org/10.2147/IJN.S201891 Text en © 2019 Abdel-Rashid et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Abdel-Rashid, Rania S
Helal, Doaa A
Omar, Mahmoud M
El Sisi, Amani M
Nanogel loaded with surfactant based nanovesicles for enhanced ocular delivery of acetazolamide
title Nanogel loaded with surfactant based nanovesicles for enhanced ocular delivery of acetazolamide
title_full Nanogel loaded with surfactant based nanovesicles for enhanced ocular delivery of acetazolamide
title_fullStr Nanogel loaded with surfactant based nanovesicles for enhanced ocular delivery of acetazolamide
title_full_unstemmed Nanogel loaded with surfactant based nanovesicles for enhanced ocular delivery of acetazolamide
title_short Nanogel loaded with surfactant based nanovesicles for enhanced ocular delivery of acetazolamide
title_sort nanogel loaded with surfactant based nanovesicles for enhanced ocular delivery of acetazolamide
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6503338/
https://www.ncbi.nlm.nih.gov/pubmed/31118616
http://dx.doi.org/10.2147/IJN.S201891
work_keys_str_mv AT abdelrashidranias nanogelloadedwithsurfactantbasednanovesiclesforenhancedoculardeliveryofacetazolamide
AT helaldoaaa nanogelloadedwithsurfactantbasednanovesiclesforenhancedoculardeliveryofacetazolamide
AT omarmahmoudm nanogelloadedwithsurfactantbasednanovesiclesforenhancedoculardeliveryofacetazolamide
AT elsisiamanim nanogelloadedwithsurfactantbasednanovesiclesforenhancedoculardeliveryofacetazolamide